| Literature DB >> 28333921 |
Anush Chiappino-Pepe1, Stepan Tymoshenko1,2, Meriç Ataman1, Dominique Soldati-Favre2, Vassily Hatzimanikatis1.
Abstract
Novel antimalarial therapies are urgently needed for the fight against drug-resistant parasites. The metabolism of malaria parasites in infected cells is an attractive source of drug targets but is rather complex. Computational methods can handle this complexity and allow integrative analyses of cell metabolism. In this study, we present a genome-scale metabolic model (iPfa) of the deadliest malaria parasite, Plasmodium falciparum, and its thermodynamics-based flux analysis (TFA). Using previous absolute concentration data of the intraerythrocytic parasite, we applied TFA to iPfa and predicted up to 63 essential genes and 26 essential pairs of genes. Of the 63 genes, 35 have been experimentally validated and reported in the literature, and 28 have not been experimentally tested and include previously hypothesized or novel predictions of essential metabolic capabilities. Without metabolomics data, four of the genes would have been incorrectly predicted to be non-essential. TFA also indicated that substrate channeling should exist in two metabolic pathways to ensure the thermodynamic feasibility of the flux. Finally, analysis of the metabolic capabilities of P. falciparum led to the identification of both the minimal nutritional requirements and the genes that can become indispensable upon substrate inaccessibility. This model provides novel insight into the metabolic needs and capabilities of the malaria parasite and highlights metabolites and pathways that should be measured and characterized to identify potential thermodynamic bottlenecks and substrate channeling. The hypotheses presented seek to guide experimental studies to facilitate a better understanding of the parasite metabolism and the identification of targets for more efficient intervention.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28333921 PMCID: PMC5363809 DOI: 10.1371/journal.pcbi.1005397
Source DB: PubMed Journal: PLoS Comput Biol ISSN: 1553-734X Impact factor: 4.475
Description of iPfa.
| Intracellular metabolites | 1017 | ||
| Cytoplasm | 499 | ||
| Mitochondrion | 171 | ||
| Apicoplast | 209 | ||
| Endoplasmic reticulum | 119 | ||
| Nucleus | 19 | ||
| Extracellular metabolites | 241 | ||
| Metabolic reactions | 670 | ||
| Cytoplasm | 374 | ||
| Mitochondrion | 97 | ||
| Apicoplast | 125 | ||
| Endoplasmic reticulum | 67 | ||
| Nucleus | 7 | ||
| Transport reactions | 396 | ||
| Cytosol—extracellular | 241 | ||
| Cytosol—mitochondrion | 58 | ||
| Cytosol—apicoplast | 58 | ||
| Cytosol—endoplasmic reticulum | 34 | ||
| Cytosol—nucleus | 5 | ||
| Cytoplasm | 328 | ||
| Mitochondrion | 83 | ||
| Apicoplast | 113 | ||
| Endoplasmic reticulum | 50 | ||
| Nucleus | 7 | ||
| Transport | 5 | ||
Fig 1Metabolic capabilities (A) and subsystems (B) defined in iPfa.
Bottleneck metabolites and affected reactions that determine the essential function of eight genes in iPfa.
| Essential Gene (E.C.) | Min. set of bottleneck metabolites | Reaction impacted after integration of the bottleneck metabolites concentration ranges | All bottleneck metabolites among alternatives | Data set description |
|---|---|---|---|---|
| (i) CTP[r], Ethanolamine[c] | (Table SIII A and Table SIII D in | CTP[r], Ethanolamine[c], Ethanolamine[r] | Required lower bound of 0.1 μM | |
| (i) CTP[r], Ethanolamine[r] | ||||
| (i) UDP-N-acetyl-D-glucosamine[c], UTP[c], UDP-glucose[c], UDP-D-galactose[c] | (Table SIII B and Table SIII D in | UDP-N-acetyl-D-glucosamine[c], UTP[c], UDP-glucose[c], UDP-D-galactose[c] | Required lower bound of 1 nM | |
| (i) GTP[c] | (Table SIII C and Table SIII D in | Diphosphate[c], GTP[c], 2,5-Diaminopyrimidine nucleoside triphosphate[c], GDP-mannose[c] | Required lower bound of 1 fM | |
| (ii) 2,5-Diaminopyrimidine nucleoside triphosphate[c] | ||||
| (i) CDP[r], CDP-ethanolamine[r], Ethanolamine phosphate[r] | R02057_r (B) | CDP[r], CDP-ethanolamine[r], Ethanolamine phosphate[r] | MS 2012 [ | |
| R01468_r (B) | ||||
| R02038_r (B) | ||||
| T_c_to_r_C00189 (B) | ||||
| R02055_r (F) | ||||
| T_c_to_r_C00065 (F) | ||||
| T_c_to_r_C00011 (R) | ||||
| (i) CMP[r], Choline[r], AMP[r], ADP[r] | R01021_r (F) | CMP[r], Choline[r], AMP[r], CTP[r], ADP[r], ATP[r] | MS 2012 [ | |
| R01890_r (F) | ||||
| R01321_r (F) | ||||
| (ii) CMP[r], Choline[r], AMP[r], ATP[r] | R01280_r (F) | |||
| R00127_r (F) | ||||
| R00094_r (F) | ||||
| (iii) CMP[r], Choline[r], AMP[r], CTP[r] | T_c_to_e_C00116 (F) | |||
| T_c_to_r_C00111 (F) | ||||
| R00842_r (R) | ||||
| (iv) CMP[r], Choline[r], CTP[r], ADP[r] | R00847_r (R) | |||
| T_c_to_r_C00013 (R) | ||||
| T_c_to_r_C00116 (R) | ||||
| (i) AMP[r], ATP[r] | R00094_r (F) | ADP[r], AMP[r], CDP-choline[c], ATP[r], CTP[r], CTP[c], CMP[r] | All the data [ | |
| R01280_r (F) | ||||
| R00127_r (F) | ||||
| T_c_to_r_C00111 (F) | ||||
| R00842_r (R) | ||||
| T_c_to_r_C00013 (R) |
1Reaction names as defined in iPfa. Metabolic reactions are defined with their R-5 digit identifier as obtained from the KEGG database. Transport reactions are marked with T_. Cellular compartments are defined with the reaction name: _r, endoplasmic reticulum; _c, cytosol; _e, extracellular (outside the parasite's cell).
2Reaction directionalities obtained with Thermodynamic Variability Analysis (TVA): (B) blocked, (F) forwards, (R) reverse. See the S4 Table for the reaction description.
Fig 2Bottleneck metabolites and substrate channeling in the production of PE.
Arrows denote reaction fluxes. Circles define metabolites. Reactions are described by their 4-digit E.C. identifier. (*) are bottleneck metabolites.
Composition of the in silico minimal media (IMMs) that allow growth of iPfa and essentiality.
| Essential | ||
| Source of amino acids | L-Isoleucine; Oxyhemoglobin | E; NE |
| Source of inorganic sulfur | Sulfate; Sulfur donor | E; E |
| Source of inorganic iron | Heme | NE |
| Cofactors and others not synthesized | Biotin; Methylcobalamin; Thiamine; Cholesterol | E; E; E; E |
| Precursors for lipoylation | Lipoate; Apoprotein | E; E |
| Precursors of lipid components | Choline; N-Acylsphingosine | E; NE |
| Precursor of FMN/FAD | Riboflavin | E |
| Precursors of isoprenoids | 4-Hydroxybenzoate; HCO3- | E; E |
| Source of inorganic phosphate | Orthophosphate or Diphosphate | NE |
| Precursors of CoA | Pantothenate or Pantetheine or N-((R)-Pantothenoyl)-L-cysteine | E |
| Source of pyridine ring (* and source of carbon) | Nicotinate D-ribonucleoside* or N-Ribosylnicotinamide* or Nicotinate or Nicotinamide | E |
| Source of DNA nucleotides (* and source of carbon) | S-adenosyl-L-methionine* or S-adenosyl-L-homocysteine* or S-adenosylmethioninamine* or Se-adenosyl-L-selenohomocysteine* or Adenosine* or Inosine* or Guanosine* or Xanthosine* or Adenine or Guanine or Hypoxanthine or Xanthine | NE |
| Source of folate and derivatives | Tetrahydrofolate (THF) or 5,10-MethyleneTHF or 10-FormylTHF or 5-MethylTHF or 5,10-MethenylTHF or Dihydrofolate or Folate or Dihydropteroate or 4-Amino-4-deoxychorismate or Chorismate or 4-Aminobenzoate | E |
| Source of pyrimidine ring (precursors of UMP) | Orotate or (S)-Dihydroorotate | E |
| Source of C2/C4 for acetyl-CoA (precursors of nucleotide sugars) | Acetate or L-2-Amino-3-oxobutanoic acid | E |
1Phenotype observed in the simulation after one-by-one depletion of the substrate or group of substrates in the in silico rich medium of 236 substrates: E, essential; NE, non-essential.
2See the next result section for explanation.
3The 10,032 alternative IMMs are generated through the combination of the constitutive metabolites and one non-constitutive metabolite from each group reported in Table 3. Note that the following constraints in the combinations should be considered: (a) the IMM should provide a ribose-containing molecule, which serves as source of carbon (marked with * in Table 3) and (b) the presence of orthophosphate and S-adenosylmethioninamine in the same IMM is not allowed (S1 Methods for more details).
Fig 3Nutritional requirements of P. falciparum concerning essential backbone moieties.
Note: the presence of orthophosphate and S-adenosylmethioninamine in the same medium is not allowed. When P. falciparum grows on orthophosphate and S-adenosylmethioninamine as the only sources of phosphate and purines, it cannot synthesize enough ATP. The ATP limitation impedes the production of other phosphorylated nucleotides, sugar nucleotides, sphingomyelin and phospholipids in the stoichiometrically required amounts. As suggested throughout the manuscript, these metabolic processes are thermodynamically dependent (more details in the S1 Methods).